IPO Boutique

Dicerna Pharmaceuticals, Inc. IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...

For IPO Boutique's "scale of 1 to 5" BUY rating on Dicerna Pharmaceuticals, Inc., and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Dicerna Pharmaceuticals, Inc.DRNA -
NASDAQ
$11.00-$13.00 $15.00 $30.006 million1/30/2014
Jefferies, Leerink Swann, Stifel
Co-Manager(s):
Baird
Health Care
Filing(s):

Filed 2013-12-31



Dicerna Pharmaceuticals, Inc. Quote & Chart - Click for current quote - DRNA

About Dicerna Pharmaceuticals, Inc. (adapted from Dicerna Pharmaceuticals, Inc. prospectus):
They are a biopharmaceutical company focused on the discovery and development of innovative treatments for rare inherited diseases involving the liver and for cancers that are genetically defined.

This description is adapted from Dicerna DRNA prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as Dicerna DRNA "DRNA" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved